9 prescriptions for the first day of using ‘eatable corona treatment’… all home therapists

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

picture explanation[사진 제공 = 연합뉴스]

On the 14th, the first day that the oral (edible) treatment for COVID-19 was used in Korea, a total of 9 confirmed cases nationwide were prescribed.

According to the Ministry of Health and Welfare’s Central Accident Resolving Headquarters (heavy water edition), as of 7 pm on the same day, nine home therapists were prescribed Pfizer’s ‘Pax Lovid’.

The first prescriber is a man in his 70s living in Daejeon. The day before, he developed symptoms of COVID-19, such as cough, and underwent a PCR (gene amplification) test. The medical staff decided to administer an oral medication.

The medical staff inquired the Drug Safe Use Service (DUR) and confirmed that the man was not taking drugs that were prohibited for use in combination with Paxrovid.

After receiving a prescription from the hospital, the pharmacy checked the DUR again, filled it and delivered it.

The 21,000 doses of food treatment purchased by the government from Pfizer arrived at Incheon International Airport the day before. Food treatment was delivered to pharmacies and living treatment centers across the country.

Excluding the adjusted quantity (7663 people) secured by the central government out of the 21,000 servings, the actual quantity delivered to home treatment pharmacies and living treatment centers is 13,337 in total.

Health authorities are prioritizing and administering the drug as the quantity of treatment is limited.

Priority should be given to patients with mild or moderate disease (between mild and severe) who are at high risk of progressing to severe disease and who are over 65 years of age or who are immunocompromised, who are receiving home treatment or are admitted to a living treatment center.

[최기성 매경닷컴 기자]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick